Compare STOK & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | PLAB |
|---|---|---|
| Founded | 2014 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2019 | 1995 |
| Metric | STOK | PLAB |
|---|---|---|
| Price | $36.53 | $49.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | $39.20 | ★ $44.33 |
| AVG Volume (30 Days) | 687.2K | ★ 889.9K |
| Earning Date | 05-12-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.73 | 9.09 |
| EPS | N/A | ★ 0.74 |
| Revenue | $184,420,000.00 | ★ $535,276,000.00 |
| Revenue This Year | N/A | $6.70 |
| Revenue Next Year | $77.49 | $4.96 |
| P/E Ratio | ★ N/A | $65.43 |
| Revenue Growth | ★ 404.50 | 18.77 |
| 52 Week Low | $8.30 | $16.59 |
| 52 Week High | $40.22 | $48.55 |
| Indicator | STOK | PLAB |
|---|---|---|
| Relative Strength Index (RSI) | 58.53 | 73.46 |
| Support Level | $30.34 | $20.85 |
| Resistance Level | $39.00 | N/A |
| Average True Range (ATR) | 1.77 | 1.82 |
| MACD | 0.34 | 0.59 |
| Stochastic Oscillator | 84.76 | 95.52 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.